Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Research & Development: 2019-2024

Historic Research & Development for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $98.4 million.

  • Cellebrite DI's Research & Development rose 8.48% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.6 million, marking a year-over-year increase of 15.91%. This contributed to the annual value of $98.4 million for FY2024, which is 16.62% up from last year.
  • Per Cellebrite DI's latest filing, its Research & Development stood at $98.4 million for FY2024, which was up 16.62% from $84.4 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Research & Development ranged from a high of $98.4 million in FY2024 and a low of $54.4 million during FY2020.
  • Over the past 3 years, Cellebrite DI's median Research & Development value was $84.4 million (recorded in 2023), while the average stood at $87.8 million.
  • Data for Cellebrite DI's Research & Development shows a peak YoY grew of 23.01% (in 2022) over the last 5 years.
  • Over the past 5 years, Cellebrite DI's Research & Development (Yearly) stood at $54.4 million in 2020, then rose by 20.53% to $65.5 million in 2021, then grew by 23.01% to $80.6 million in 2022, then increased by 4.67% to $84.4 million in 2023, then increased by 16.62% to $98.4 million in 2024.